What is it about?
We show the synthesis and evaluation of new compounds designed as hybrids between eugenol and benzisoxazolinones as a new antifungal scaffolds.
Featured Image
Why is it important?
Our findings show new prototypes to be studied as antifungal drugs and these findings contribute to drug discovery, since fungal infections are an increasing risk and need new drugs more than ever.
Perspectives
We hope this paper may be used for other scientists as a starting point in the synthesis of optimized derivatives against fungal infections.
Diogo Teixeira carvalho
Universidade Federal de Alfenas
Read the Original
This page is a summary of: A New 1,2-Benzisoxazolin-3-one Synthetized from Eugenol Shows Anti- Candida Spp. Activity, Specially Against Opportunistic Candida Glabrata, Current Bioactive Compounds, June 2021, Bentham Science Publishers,
DOI: 10.2174/1573407216999200723114241.
You can read the full text:
Contributors
The following have contributed to this page
